Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H Financial Overview
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H's market cap is currently HK$11.23B. The company's EPS TTM is HK$0.1321322508; its P/E ratio is 75.05; Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H is scheduled to report earnings on August 28, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
